CVRx (CVRX) Other Current Payables: $0.00 Mil (As of Mar. 2026)


CVRX CVRx Inc CVRX
57 GF Score
Price $5.64
GF Value $11.24
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is CVRx Other Current Payables?

CVRx CVRX +2.47% 57 Other Current Payables is $0.00 Mil as of Mar. 2026. GuruFocus rates CVRX with a GF Score™ of 57/100 and a GF Value™ of $11.24 (Possible Value Trap). The stock has 4 warning signs investors should review.

CVRx's Other Current Payables for the quarter that ended in Mar. 2026 was $0.00 Mil.

CVRx's quarterly Other Current Payables increased from Sep. 2025 ($-0.00 Mil) to Dec. 2025 ($0.00 Mil) but then stayed the same from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($0.00 Mil).

CVRx's annual Other Current Payables increased from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) but then declined from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($0.00 Mil).

CVRx Other Current Payables Related Terms

CVRx Other Current Payables Historical Data

* Premium members only.

The historical data trend for CVRx's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CVRx Other Current Payables Chart

CVRx Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

CVRx Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.00 0.00 0.00
CVRX
57GF Score
CVRx Inc CVRX
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVRx Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of $0.00 Mil mean?
CVRx (CVRX) has a Other Current Payables of $0.00 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on CVRx and its competitors.
Is CVRx's Other Current Payables too high?
CVRx's current Other Current Payables is $0.00 Mil. Overall, CVRx has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CVRx's Other Current Payables compare to OWLT and HYPR?
CVRx's Other Current Payables of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on CVRx and its competitors. CVRx's current Other Current Payables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVRx stock overvalued right now?
Based on GuruFocus' analysis, CVRx (CVRX) is currently considered Possible Value Trap. The stock's GF Value™ is $11.24, compared to a current price of $5.64 — trading 49.9% below its estimated fair value. The current Other Current Payables is $0.00 Mil. CVRx's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For CVRx (CVRX), the current Other Current Payables is $0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVRx (CVRX) Overvalued in 2026?

Based on GuruFocus' analysis, CVRx stock appears to be undervalued. The current stock price of $5.64 is trading 49.9% below its estimated GF Value™ of $11.24. GuruFocus considers CVRx to be Possible Value Trap.

Key valuation signals for CVRX:

  • Other Current Payables: $0.00 Mil
  • GF Value™: $11.24 vs. price of $5.64 (49.9% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the CVRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CVRx Business Description

Address 9201 West Broadway Avenue, Suite 650, Minneapolis, MN, USA, 55445
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
57GF Score

Get the complete analysis for CVRX

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.64
Price
$11.24
GF Value